CEO of Triplet Therapeutics
A therapeutics company developing siRNA and ASO therapeutics that target repeat expansion disorders such as Huntington’s disease, myotonic dystrophy and spinocerebellar ataxias
F-star is an antibody Engineering founded in 2012.